>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:
  • HAIN -26.2%, (Hain Celestial delays release of its Q4 and FY16 results; also, co does not expect to achieve its previously announced guidance for FY16)
  • HTBX -12.9%, (also enters into At Market Issuance Sales Agreement to sell up to $10.5 mln in shares of its common stock),REPH -11.8%, EVOK -9.2%
  • ALRM -5.9%, CHCI -5.6%, SID -5.2%, TJX -4.6%, IMNP -4.4%, RENN -4.1%, AAP -3.4%, AFCO -2.5%, ASM -1.4%,PRKR -1.3%
Other news:
  • OGXI -34.4% (Phase 3 AFFINITY trial of Custirsen in men with metastatic castrate-resistant prostate cancer did not meet the primary endpoint)
  • REPH -11.8% (Recro Pharma intends to offer and sell shares of its common stock in an underwritten public offering)
  • UNVR -6% (prices offering of 20,943,741 shares of Univar's common stock at $19/share by selling shareholders )
  • GALT -5.8% (Galectin Therapeutics files for 2 mln share common stock offering by selling shareholders)
  • HPT -4.2% (prices offering of 11 mln shares of common stock at $30.75 per share)
  • OCUL -3.9% (modestly pulling back following recent multiple day strength)
  • CXO -3.8% (prices 9 mln shares of common stock for total gross proceeds of ~$1.18 bln)
  • GBDC -2.7% ( to make a public offering of 1,750,000 shares of its common stock)
  • VRTX -2.4% (updates on its Phase 3 development program of its VX-661 in combination with ivacaftor; plans to stop the study of VX-661 and ivacaftor in people with one copy of the F508del mutation after DSMB review)
  • PE -2.1% (Parsley Energy to acquire certain undeveloped acreage and producing oil and gas properties, as well as associated mineral and overriding royalty interests, for an aggregate purchase price of $400 mln; commenced an underwritten public offering of 7,000,000 shares of Class A common stock)
  • ATVI -2% (still checking - Paulson disclosed decreased position, while Lone Pine disclosed new position)
  • SHOP -1.5% (Shopify files prelim prospectus supplement to its short form base shelf prospectus dated August 5; 7.5 mln Class A subordinate voting shares will be offered for sale under the Offering )
  • PCG -0.7% ( commences 4.9 mln common stock offering)
Analyst comments:
  • JPM -0.8% (downgraded to Market Perform from Outperform at Bernstein)